This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Changes to Greek Covid program for repayable advances win EU state aid approval

( July 1, 2021, 16:14 GMT | Official Statement) -- MLex Summary: A budget increase of 1.5 billion euros ($1.8 billion) for Greece's repayable advances program for companies affected by Covid-19 has received European Commission approval. The program was initially cleared in April last year. This is the fourth amendment. It also includes an extension of the period for which aid can be granted and relaxed conditions for newly created companies.Press release follows....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections